Spyglass Pharma, Inc. is a clinical-stage biopharmaceutical company dedicated to revolutionizing the treatment of chronic ophthalmic diseases through its innovative drug delivery platform. The company's primary focus is on addressing the challenges of patient compliance and the limitations of traditional eye drop therapies, which are often the standard of care for conditions like glaucoma. Spyglass Pharma's core technology is a proprietary drug-eluting intraocular lens (IOL) platform. This system is designed to be implanted during routine cataract surgery, providing a controlled, long-term release of medication directly into the eye. By automating drug delivery at the source, the company aims to provide a more consistent and effective treatment regimen for patients suffering from glaucoma and ocular hypertension, significantly reducing the burden of daily self-administration. The company's lead product candidate utilizes this platform to deliver bimatoprost, a well-established medication for lowering intraocular pressure, over an extended period. This approach seeks to eliminate the high rates of non-compliance associated with topical drops. Spyglass Pharma is currently advancing its platform through clinical trials to establish the safety and efficacy of its delivery system. Headquartered in Aliso Viejo, California, Spyglass Pharma was co-founded by industry veterans and clinicians with extensive experience in ophthalmology and medical device development. The company is supported by leading venture capital investors and continues to explore the application of its technology to a broader range of ocular conditions beyond its initial focus on glaucoma.
The sum of declared dividends issued by a company for every ordinary share outstanding.
Dividend Yield is a financial ratio that shows how much a company pays out in dividends each year relative to its share price in the last twelve months. In the absence of any capital gains, the dividend yield is the return on investment for a stock.
It is another way that companies have to remunerate their shareholders, being an alternative to dividends. Shows the % of repurchases per share made in the last 12 months in relation to the share price.
Sum of Dividend Yield and BuyBack Yield to show the total return that the shareholder received in the last 12 months in relation to the share price.
The dividend payout ratio is the ratio of the total amount of dividends paid out to shareholders relative to the net income of the company. It is the percentage of earnings paid to shareholders via dividends.
Retained earnings (RE) are the amount of net income left over for the business after it has paid out dividends to its shareholders and are an important variable for assessing a company's financial health because it shows the net income that a company has saved over time, and therefore has the ability to reinvest in the business or distribute to shareholders.
...and much more!